Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cyteir Therapeutics (CYT)
NASDAQ:CYT
RESEARCH TOOLSreports
Cyteir Therapeutics (CYT) Financial Statements
24 Followers
Cyteir Therapeutics Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -3.53M | $ -8.40M | $ -14.02M | $ -8.79M | $ -11.76M |
| EBITDA | $ -3.43M | $ -8.30M | $ -13.82M | $ -8.59M | $ -11.59M |
| Net Income Common Stockholders | $ -3.53M | $ -8.40M | $ -12.48M | $ -8.79M | $ -11.04M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 129.24M | $ 133.63M | $ 137.20M | $ 147.12M | $ 153.89M |
| Total Assets | $ 131.01M | $ 134.39M | $ 138.98M | $ 153.23M | $ 161.70M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 900.00K |
| Net Debt | $ -129.24M | $ -133.63M | $ -137.20M | $ -147.12M | $ -152.99M |
| Total Liabilities | $ 5.98M | $ 6.60M | $ 4.00M | $ 6.95M | $ 7.66M |
| Stockholders Equity | $ 125.03M | $ 127.79M | $ 134.98M | $ 146.29M | $ 154.03M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.56M | $ -4.00M | $ -9.97M | $ -6.92M | $ -12.58M |
| Operating Cash Flow | $ -4.56M | $ -4.16M | $ -10.12M | $ -6.92M | $ -12.57M |
| Investing Cash Flow | - | $ 153.00K | $ 150.00K | - | $ -10.00K |
| Financing Cash Flow | $ 164.00K | $ 428.00K | $ 103.00K | $ 147.00K | $ 71.00K |
Cyteir Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.